SYSTEMATIC REVIEW OF BIOMARKERS FOR DISEASE PROGRESSION IN ALZHEIMER'S DISEASE
نویسندگان
چکیده
منابع مشابه
A Systematic Review of Biomarkers for Disease Progression in Alzheimer's Disease
BACKGROUND Using surrogate biomarkers for disease progression as endpoints in neuroprotective clinical trials may help differentiate symptomatic effects of potential neuroprotective agents from true slowing of the neurodegenerative process. A systematic review was undertaken to determine what biomarkers for disease progression in Alzheimer's disease exist and how well they perform. METHODS ME...
متن کاملA systematic review of biomarkers for disease progression in Parkinson’s disease
BACKGROUND Using surrogate biomarkers for disease progression as endpoints in neuroprotective clinical trials may help differentiate symptomatic effects of potential neuroprotective agents from true disease-modifying effects. A systematic review was undertaken to determine what biomarkers for disease progression in Parkinson's disease (PD) exist. METHODS MEDLINE and EMBASE (1950-2010) were se...
متن کاملCorrection: A Systematic Review of Biomarkers for Disease Progression in Alzheimer's Disease
Citation: The PLOS ONE Staff (2014) Correction: A Systematic Review of Biomarkers for Disease Progression in Alzheimer’s Disease. PLoS ONE 9(5): e97960. doi:10.1371/journal.pone.0097960 Published: May 15, 2014 Copyright: 2014 The PLOS ONE Staff. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, a...
متن کاملRab11 in Disease Progression
Membrane/ protein trafficking in the secretory/ biosynthetic and endocytic pathways is mediated by vesicles. Vesicle trafficking in eukaryotes is regulated by a class of small monomeric GTPases the Rab protein family. Rab proteins represent the largest branch of the Ras superfamily GTPases, and have been concerned in a variety of intracellular vesicle trafficking and different intracellular sig...
متن کاملAlzheimers Disease: Review of Emerging Treatment Role for Intravenous Immunoglobulins
Alzheimer's disease (AD) is the most common neurodegenerative disorder. Currently available therapies are symptomatic but do not alter underlying disease progression. Immunotherapeutic approaches such as anti Aβ peptide active vaccination trials have had limited success to date. Intravenous immunoblobulin (IVIg) is widely used in immune-mediated neurological disorders such myasthenia gravis and...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Neurology, Neurosurgery & Psychiatry
سال: 2013
ISSN: 0022-3050,1468-330X
DOI: 10.1136/jnnp-2013-306573.87